+Compare
AZN
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
225.07B

AZN Price Prediction, AstraZeneca PLC AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for AZN with price predictions
08:00 PM EDT Jun 01, 2023

AZN's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for AZN moved out of oversold territory on May 26, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where AZN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AZN advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .

AZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 18, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on AZN as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AZN moved below its 50-day moving average on June 01, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AZN crossed bearishly below the 50-day moving average on June 02, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AZN entered a downward trend on May 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.285) is normal, around the industry mean (6.298). P/E Ratio (48.077) is within average values for comparable stocks, (31.116). Projected Growth (PEG Ratio) (2.130) is also within normal values, averaging (3.496). Dividend Yield (0.020) settles around the average of (0.027) among similar stocks. P/S Ratio (5.165) is also within normal values, averaging (4.102).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I. Advisor
published Earnings

AZN is expected to report earnings to rise 1.33% to 97 cents per share on July 27

AstraZeneca PLC AZN Stock Earnings Reports
Q2'23
Est.
$0.97
Q1'23
Beat
by $0.11
Q4'22
Beat
by $0.02
Q3'22
Beat
by $0.90
Q2'22
Beat
by $0.08
The last earnings report on April 27 showed earnings per share of 95 cents, beating the estimate of 85 cents. With 8.04M shares outstanding, the current market capitalization sits at 225.07B.
A.I.Advisor
published Dividends

AZN paid dividends on March 27, 2023

AstraZeneca PLC AZN Stock Dividends
А dividend of $0.99 per share was paid with a record date of March 27, 2023, and an ex-dividend date of February 23, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.73B. The market cap for tickers in the group ranges from 72.83K to 419.89B. LLY holds the highest valuation in this group at 419.89B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 1%. DCHPF experienced the highest price growth at 52%, while CHJTF experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was 9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 57
Price Growth Rating: 54
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
83500
Web
https://www.astrazeneca.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSYS16.211.64
+11.26%
Stratasys Ltd
GBIO3.930.37
+10.39%
Generation Bio Co
PYCR23.101.06
+4.81%
Paycor HCM
KAVL0.660.03
+4.65%
Kaival Brands Innovations Group
APH77.571.75
+2.31%
Amphenol Corp

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with NVS. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.34%
NVS - AZN
61%
Loosely correlated
+1.85%
PFE - AZN
50%
Loosely correlated
+0.89%
SNY - AZN
48%
Loosely correlated
+1.09%
MRK - AZN
45%
Loosely correlated
+1.43%
LLY - AZN
45%
Loosely correlated
+1.34%
More